Johnson & Johnson Research and development expenses
Research & Development (R&D) expenses of Johnson & Johnson 2001-2021
Amounts are in $millions
| Year | R&D expenses ($m) |
| 2021 | $14,714 |
| 2020 | $12,159 |
| 2019 | $11,355 |
| 2018 | $10,775 |
| 2017 | $10,594 |
| 2016 | $9,143 |
| 2015 | $8,999 |
| 2014 | $8,471 |
| 2013 | $8,119 |
| 2012 | $,602 |
| 2011 | $7,486 |
| 2010 | $6,796 |
| 2009 | $6,949 |
| 2008 | $7,554 |
| 2007 | $7,680 |
| 2006 | $7,125 |
| 2005 | $6,462 |
| 2004 | $5,344 |
| 2003 | $4,834 |
| 2002 | $4,094 |
| 2001 | $3,704 |
2021: Johnson & Johsnon spent $14,714 million on research and development in 2021 compared to $12,159 million in 2020. Its R&D expenses were 15.7% of its total net sales in 2021 compared to 14.7% in 2020. The company's R&D expenses grew by 21% in 2021 compared to 2020. Out of the total that the company spent on R&D, the largest portion was devoted to R&D in the pharmaceutical segment. Johnson & Johnson's pharmaceutical related R&D expenses were $11,882 million in 2021 compared to $9,563 million in 2020.
2018: Research and deevlopment expenses (R&D) expenses of Johnson & Johnson reached $10,775 million in 2018 from $10,594 million in 2017.